GLP-1 pills are coming, and they could revolutionize weight-loss
网页2024年9月17日 · The new crop of GLP-1 weight loss drugs all come in the form of injections. New pill versions are in trials now. Illustration by Leah Abucayan/CNN. CNN — Jared Holz thought about taking one of...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
网页The drug combines GLP-1 and glucagon. In a phase 3 study of adults in China who were overweight or had obesity, researchers found that after 48 weeks, a 6-milligram dose of the drug led to an ...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
网页2024年5月21日 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
网页Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
网页2023年10月30日 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
GLP-1 Drugs Are Coming, and They Could Change Everything
网页2023年8月18日 · GLP-1 medications including Ozempic, Wegovy and Mounjaro were created to treat diabetes but have since been found to suppress appetites and induce substantial weight loss.
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug ... - CNN
网页2024年5月10日 · About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people –...
Research shows GLP-1 drugs are effective but complex
网页2024年5月30日 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
FDA approves first oral GLP-1 treatment for type 2 diabetes
网页The U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise.
After GLP-1, what’s next for weight loss? - Nature
网页2023年6月6日 · Wegovy mimics the effects of glucagon-like peptide 1 (GLP-1), a hormone released by the gut’s L cells in response to food. GLP-1 stimulates pancreatic cells to release insulin and lower blood...
跳至内容